Heart disease and stroke statistics—2019 update: a report from the American Heart Association

EJ Benjamin, P Muntner, A Alonso, MS Bittencourt… - Circulation, 2019 - ahajournals.org
Summary Each year, the American Heart Association (AHA), in conjunction with the National
Institutes of Health and other government agencies, brings together in a single document the …

Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy

S Kraler, MC Blaser, E Aikawa, GG Camici… - European heart …, 2022 - academic.oup.com
Calcific aortic valve disease (CAVD) is a highly prevalent condition that comprises a disease
continuum, ranging from microscopic changes to profound fibro-calcific leaflet remodelling …

Heart disease and stroke statistics—2020 update: a report from the American Heart Association

SS Virani, A Alonso, EJ Benjamin, MS Bittencourt… - Circulation, 2020 - ahajournals.org
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports on the most up-to-date statistics related to heart disease, stroke …

Heart disease and stroke statistics-2021 update: a report from the American Heart Association.

SS Virani, A Alonso, HJ Aparicio, EJ Benjamin… - Circulation, 2021 - europepmc.org
Background The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

The global burden of valvular heart disease: from clinical epidemiology to management

G Santangelo, F Bursi, A Faggiano… - Journal of clinical …, 2023 - mdpi.com
Valvular heart disease is a leading cause of cardiovascular morbidity and mortality and a
major contributor of symptoms and functional disability. Knowledge of valvular heart disease …

Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategies

J Rangaswami, RO Mathew… - Nephrology Dialysis …, 2019 - academic.oup.com
Kidney transplantation (KT) is the optimal therapy for end-stage kidney disease (ESKD),
resulting in significant improvement in survival as well as quality of life when compared with …

[HTML][HTML] Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

TH Marwick, K Amann, S Bangalore, JL Cavalcante… - Kidney international, 2019 - Elsevier
Chronic kidney disease (CKD) is a major risk factor for valvular heart disease (VHD). Mitral
annular and aortic valve calcifications are highly prevalent in CKD patients and commonly …

Kidney dysfunction and the risk of develo** aortic stenosis

G Vavilis, M Bäck, G Occhino, M Trevisan… - Journal of the American …, 2019 - jacc.org
Background Chronic kidney disease (CKD) and aortic stenosis (AS) share many risk factors.
Objectives This study sought to evaluate whether kidney dysfunction is associated with the …

Evaluation and management of aortic stenosis in chronic kidney disease: a scientific statement from the American Heart Association

GR Shroff, S Bangalore, NM Bhave, TI Chang… - Circulation, 2021 - ahajournals.org
Aortic stenosis with concomitant chronic kidney disease (CKD) represents a clinical
challenge. Aortic stenosis is more prevalent and progresses more rapidly and unpredictably …

Cardiovascular complications of chronic kidney disease: an introduction

H Warrens, D Banerjee… - European Cardiology …, 2022 - pmc.ncbi.nlm.nih.gov
Cardiovascular disease (CVD) is the primary cause of morbidity and mortality in chronic
kidney disease (CKD). CVD mortality risk doubles and triples in CKD stages 3 and 4 …